HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon third quarter

This article was originally published in The Rose Sheet

Executive Summary

International business drove sales up 11.2% in the third quarter to $1.78 bil., the direct seller announces Oct. 29. Beauty sales for the period increased 15% to $1.23 bil. Sales in Latin America grew 8% in dollars, while in Europe, sales jumped 24% and in Asia Pacific, 14%. Gains offset U.S. sales decline of 1% to $502.6 mil., "reflecting weak consumer response to color cosmetics promotions in advance of a later September category relaunch, and under-performance in children's apparel and toys," Avon says. Operating profit in the region fell 9%. Going forward, the firm intends to exit certain categories of Beyond Beauty, which declined 6% in Q3, to restore the U.S. business to healthy growth. Avon consolidated net income jumped 32.9% to $176.9 mil. in the quarter ...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel